Deutsche Bank Ag\ Revance Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 62,694 shares of RVNC stock, worth $161,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,694

Previous 37,061 69.16%

Holding current value

$161,123

Previous $95,000 69.47%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.57 - $2.57 $65,876 - $65,876	25,633 Added 69.16%	62,694 $161,000
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $19,581 - $39,580	-8,368 Reduced 18.42%	37,061 $95,000
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $5,240 - $10,492	1,127 Added 2.54%	45,429 $223,000
Q4 2023 Feb 14, 2024	SELL	$5.81 - $11.2 $4,299 - $8,288	-740 Reduced 1.64%	44,302 $389,000
Q3 2023 Nov 09, 2023	BUY	$11.47 - $25.07 $59,644 - $130,364	5,200 Added 13.05%	45,042 $516,000
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $436,597 - $664,794	-17,676 Reduced 30.73%	39,842 $1.01 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $1.85 Million - $3.56 Million	-100,801 Reduced 63.67%	57,518 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$18.32 - $30.66 $2.31 Million - $3.86 Million	125,982 Added 389.59%	158,319 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $123,467 - $245,297	-8,616 Reduced 21.04%	32,337 $873,000
Q2 2022 Aug 11, 2022	SELL	$11.52 - $20.4 $55,399 - $98,103	-4,809 Reduced 10.51%	40,953 $566,000
Q1 2022 May 13, 2022	SELL	$12.36 - $20.31 $60,539 - $99,478	-4,898 Reduced 9.67%	45,762 $892,000
Q4 2021 Feb 11, 2022	BUY	$12.46 - $27.87 $34,439 - $77,032	2,764 Added 5.77%	50,660 $827,000
Q3 2021 Nov 04, 2021	SELL	$25.78 - $33.21 $381,311 - $491,209	-14,791 Reduced 23.6%	47,896 $1.33 Million
Q2 2021 Aug 11, 2021	SELL	$26.8 - $31.84 $2.06 Million - $2.44 Million	-76,766 Reduced 55.05%	62,687 $1.86 Million
Q1 2021 May 13, 2021	BUY	$24.03 - $29.97 $2.14 Million - $2.67 Million	89,178 Added 177.38%	139,453 $3.9 Million
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $293,022 - $354,731	12,517 Added 33.15%	50,275 $1.42 Million
Q3 2020 Nov 12, 2020	SELL	$23.23 - $34.3 $2.25 Million - $3.32 Million	-96,809 Reduced 71.94%	37,758 $949,000
Q2 2020 Aug 13, 2020	SELL	$12.6 - $26.55 $520,317 - $1.1 Million	-41,295 Reduced 23.48%	134,567 $3.29 Million
Q1 2020 May 14, 2020	BUY	$12.46 - $27.81 $251,069 - $560,371	20,150 Added 12.94%	175,862 $2.6 Million
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $1.45 Million - $2.51 Million	124,438 Added 397.9%	155,712 $2.53 Million
Q3 2019 Nov 14, 2019	SELL	$10.22 - $14.5 $4.85 Million - $6.88 Million	-474,262 Reduced 93.81%	31,274 $404,000
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $371,198 - $538,881	34,789 Added 7.39%	505,536 $6.56 Million
Q1 2019 May 15, 2019	BUY	$15.4 - $20.39 $2.14 Million - $2.83 Million	138,927 Added 41.87%	470,747 $7.42 Million
Q4 2018 Feb 14, 2019	BUY	$18.06 - $24.96 $1.77 Million - $2.45 Million	98,257 Added 42.07%	331,820 $6.68 Million
Q3 2018 Dec 21, 2021	BUY	$23.55 - $30.1 $328,192 - $419,473	13,936 Added 6.35%	233,563 $5.8 Million
Q3 2018 Nov 14, 2018	SELL	$23.55 - $30.1 $1.83 Million - $2.34 Million	-77,893 Reduced 26.18%	219,627 $5.46 Million
Q2 2018 Apr 21, 2020	BUY	$27.45 - $33.35 $459,128 - $557,812	16,726 Added 5.96%	297,520 $8.17 Million
Q2 2018 Aug 14, 2018	BUY	$27.45 - $33.35 $3.1 Million - $3.77 Million	113,055 Added 67.4%	280,794 $7.71 Million
Q1 2018 Oct 18, 2019	BUY	$29.15 - $37.4 $435,267 - $558,456	14,932 Added 9.77%	167,739 $5.17 Million
Q1 2018 May 15, 2018	BUY	$29.15 - $37.4 $708,898 - $909,530	24,319 Added 18.93%	152,807 $4.71 Million
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $343,994 - $508,635	14,012 Added 12.24%	128,488 $4.59 Million
Q3 2017 Nov 14, 2017	BUY	$22.55 - $28.1 $2.58 Million - $3.22 Million	114,476	114,476 $3.15 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account